China wafer champion turns to US$1.6B overhaul to stop losses

National Silicon Industry Group’s $1.6B capital injection into Shanghai-based Xinsheng isn’t merely a bailout—it’s a strategic bet on China’s self-reliance in 300mm wafers. Technically, this accelerates domestic equipment and material validation but won’t displace Shin-Etsu or SUMCO in high-end epitaxial wafers soon. Tightening U.S. export controls force Chinese firms into costly hybrid sourcing—boosting operational risk and lead times. Competitors like GlobalWafers and Taiwan, China’s Powerchip may deepen ties with Samsung and SK Hynix to lock in mature-node wafer demand. Over the next 18 months, if Xinsheng fails to achieve monthly cash-flow positivity, this move becomes fiscal trench-filling; if successful, it could catalyze a self-sustaining domestic wafer ecosystem, reshaping global supply dynamics.